FDA approval of new drug for Alzheimer’s provides a “significant ray of hope”
The approval by the U.S. Food and Drug Administration (FDA) earlier this month of the drug aducanumab (Biogen/Eisai) to help treat Alzheimer’s disease created plenty of excitement and optimism
[ Read More ]